The covert effort began under Trump and continued into Biden’s presidency, Reuters found. Health experts say it endangered lives for possible geopolitical gain.

That compares to 44,974 cases reported at roughly the same time three years ago. experts say they worry the rate of vaccination against the virus will continue to fall as the number of COVID-19 ...

MSD will soon enter the market for drugs used to protect infants from respiratory syncytial virus (RSV) infections after getting approval from the FDA for its antibody therapy Enflonsia.

The U.S. Centers for Disease Control and Prevention's revamped vaccine advisory panel on Wednesday postponed its vote on the use of respiratory syncytial virus therapies to Thursday.